These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29559524)

  • 1. Activity-Based Detection of Cannabinoids in Serum and Plasma Samples.
    Cannaert A; Storme J; Hess C; Auwärter V; Wille SMR; Stove CP
    Clin Chem; 2018 Jun; 64(6):918-926. PubMed ID: 29559524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity-Based Detection of Consumption of Synthetic Cannabinoids in Authentic Urine Samples Using a Stable Cannabinoid Reporter System.
    Cannaert A; Franz F; Auwärter V; Stove CP
    Anal Chem; 2017 Sep; 89(17):9527-9536. PubMed ID: 28771321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous detection of 93 synthetic cannabinoids by liquid chromatography-tandem mass spectrometry and retrospective application to real forensic samples.
    Hess C; Murach J; Krueger L; Scharrenbroch L; Unger M; Madea B; Sydow K
    Drug Test Anal; 2017 May; 9(5):721-733. PubMed ID: 27400642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
    Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
    Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity-Based Concept to Screen Biological Matrices for Opiates and (Synthetic) Opioids.
    Cannaert A; Vasudevan L; Friscia M; Mohr ALA; Wille SMR; Stove CP
    Clin Chem; 2018 Aug; 64(8):1221-1229. PubMed ID: 29776952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Fast and Comprehensive Analysis of 32 Synthetic Cannabinoids Using Agilent Triple Quadrupole LC-MS-MS.
    Borg D; Tverdovsky A; Stripp R
    J Anal Toxicol; 2017 Jan; 41(1):6-16. PubMed ID: 27681343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive library-based, automated screening procedure for 46 synthetic cannabinoids in serum employing liquid chromatography-quadrupole ion trap mass spectrometry with high-temperature electrospray ionization.
    Huppertz LM; Kneisel S; Auwärter V; Kempf J
    J Mass Spectrom; 2014 Feb; 49(2):117-27. PubMed ID: 24677304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dried haematic microsamples and LC-MS/MS for the analysis of natural and synthetic cannabinoids.
    Protti M; Rudge J; Sberna AE; Gerra G; Mercolini L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():77-86. PubMed ID: 28088044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry.
    Scheidweiler KB; Jarvis MJ; Huestis MA
    Anal Bioanal Chem; 2015 Jan; 407(3):883-97. PubMed ID: 25224637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid and sensitive screening and confirmation of thirty-four aminocarbonyl/carboxamide (NACA) and arylindole synthetic cannabinoid drugs in human whole blood.
    Tynon M; Homan J; Kacinko S; Ervin A; McMullin M; Logan BK
    Drug Test Anal; 2017 Jun; 9(6):924-934. PubMed ID: 27653946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LC/ESI-MS/MS method for quantification of 28 synthetic cannabinoids in neat oral fluid and its application to preliminary studies on their detection windows.
    Kneisel S; Speck M; Moosmann B; Corneillie TM; Butlin NG; Auwärter V
    Anal Bioanal Chem; 2013 May; 405(14):4691-706. PubMed ID: 23535743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hair analysis as a tool to evaluate the prevalence of synthetic cannabinoids in different populations of drug consumers.
    Salomone A; Luciano C; Di Corcia D; Gerace E; Vincenti M
    Drug Test Anal; 2014; 6(1-2):126-34. PubMed ID: 24115381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction.
    Kneisel S; Auwärter V
    J Mass Spectrom; 2012 Jul; 47(7):825-35. PubMed ID: 22791249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Synthetic Cannabinoid Metabolites by Liquid Chromatography-Tandem Mass Spectrometry.
    Janis GC
    Methods Mol Biol; 2019; 1872():137-147. PubMed ID: 30350287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
    Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA
    Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity-based reporter assays for the screening of abused substances in biological matrices.
    Cannaert A; Vandeputte M; Wille SMR; Stove CP
    Crit Rev Toxicol; 2019 Feb; 49(2):95-109. PubMed ID: 30919714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry.
    Vikingsson S; Gréen H; Brinkhagen L; Mukhtar S; Josefsson M
    Drug Test Anal; 2016 Sep; 8(9):950-6. PubMed ID: 26560240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance characteristics of an ELISA screening assay for urinary synthetic cannabinoids.
    Spinelli E; Barnes AJ; Young S; Castaneto MS; Martin TM; Klette KL; Huestis MA
    Drug Test Anal; 2015 Jun; 7(6):467-74. PubMed ID: 25167963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicological findings of synthetic cannabinoids in recreational users.
    Kronstrand R; Roman M; Andersson M; Eklund A
    J Anal Toxicol; 2013 Oct; 37(8):534-41. PubMed ID: 23970540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MS.
    Hutter M; Broecker S; Kneisel S; Franz F; Brandt SD; Auwarter V
    Curr Pharm Biotechnol; 2018; 19(2):144-162. PubMed ID: 29745330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.